Dr. Sherry Hsiang-Yi Chou: Faculty Experts
Not seeing the results that match your search? FILTER BY CATEGORY AND FIELD
Dr. Sherry Hsiang-Yi Chou
Northwestern University Feinberg School of Medicine
Chief, Division of Neurocritical Care
Associate Professor, Department of Neurology
About
Areas of Focus
- Neurological presentations and impact of COVID-19
- Brain aneurysm and brain injury from subarachnoid hemorrhage
- Intensive care of stroke and acute brain injury
- Traumatic brain injury
- Brain dysfunction in critical illness
- Biomarkers of brain injury
- Coma and disorders of consciousness
Work/Research
- Neurological manifestations of acute COVID-19
- Brain injury due to subarachnoid hemorrhage
- Biomarkers of brain injury
- Brain-body interaction in acute brain injuries
- Encephalopathy in COVID-19
Career
Dr. Sherry Chou is a physician-scientist with clinical expertise in neurology, vascular neurology and neurocritical care. Dr. Chou studied Medicine at McGill University (Montreal, Canada) and completed clinical training at the Massachusetts General Hospital, Brigham and Women’s Hospital, and Harvard Medical School. She served as assistant professor of Neurology at Harvard Medical School, and subsequently as associate professor of Critical Care Medicine at the University of Pittsburgh. She now serves as the Chief of Neurocritical Care Division and Associate Professor of Neurology at Northwestern University Feinberg School of Medicine. She also serves as a member of the Board of Directors of the Neurocritical Care Society. Dr. Chou has served on multiple international consensus and guidelines committees for the American Heart Association and the Neurocritical Care Society.
Dr. Chou’s research program focuses on the role of inflammation and immune response in vascular brain injuries and biomarker discovery in critically ill patients, specifically in subarachnoid hemorrhage (SAH). Dr. Chou has extensive experience in building multicenter human biorepository and biomarker studies and clinical trials in SAH. Dr. Chou’s expertise also includes clinical trials in the neurocritical care patient population, including services on clinical endpoints committees, data and safety monitoring boards and scientific advisory boards for clinical trials in strokes and brain injury. Shortly after the onset of COVID-19 pandemic, Dr. Chou and colleagues founded and led the Global Consortium Study of Neurologic Manifestations of COVID-19 (GCS-NeuroCOVID) published the largest international cohort study on neurologic dysfunctions of COVID-19 capturing the first phases of this pandemic.
Dr. Chou’s publications can be found at:
https://www.ncbi.nlm.nih.gov/myncbi/sherry.chou.1/bibliography/public/